Products
What will AGI do for Antipsychotics?
Alters neurotransmitter pathways in the brain, primarily targeting dopamine and serotonin receptors, to manage symptoms of schizophrenia, bipolar disorder, and acute psychosis. Representative products within this family include first-generation typical antipsychotic tablets, second-generation atypical capsules, and long-acting intramuscular injections.